Eddy Kizana
Professor
Centre Director
MBBS/PhD
eddy.kizana@sydney.edu.au
Currently open to PHD and Honours students in the topic areas of:
AAV based gene therapy for cardiac applications
Biography
Dr Kizana is a cardiologist at Westmead Hospital who has developed a research program at The Westmead Insitute for Medical Research using gene therapy technology for the treatment of cardiac disease in humans. The research program consists of vector technology development and the application of these in pre-clinical models of human disease. The research is translational and highly collaborative.
Research interests
Cardiac Gene Therapy, AAV vector development, Preclinical models of heart disease
Adjunct roles
| Cardiologist | Westmead Hospital |
| Associate Professor | Sydney Medical School, The University of Sydney |
Recent publications
Gene therapy in cardiology: is a cure for hypertrophic cardiomyopathy on the horizon? Can J Cardiol.
Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytes.
Recombinant Adeno-Associated Viral Vector-Mediated Gene Transfer of hTBX18 Generates Pacemaker Cells from Ventricular Cardiomyocytes.
Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer.
Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method. Viruses.
Additional information
ORCID: https://orcid.org/0000-0002-7266-6720
USYD link – https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/eddy-kizana.html
Related News
Current grants
| NHMRC/MRFF | 2023-2026 | Gap Junction Modulation: A Novel Molecular Target in the Management of Ventricular Arrhythmia in Ischaemic Cardiomyopathy |
| NSW Health Cardiovascular Capacity Grant | 2022-2024 | Overcoming the barrier to human cardiac gene therapy |
Affiliations
Westmead Hospital, University of Sydney
